Tourmaline Bio (TRML) Earnings Date, Estimates & Call Transcripts $21.48 +0.49 (+2.33%) Closing price 04:00 PM EasternExtended Trading$21.46 -0.02 (-0.09%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tourmaline Bio Earnings Summary Tourmaline Bio announced Q1 2025 earnings on May 2, 2025, reporting an EPS of -$0.89, which beat analysts' consensus estimates of -$0.91 by $0.02. With a trailing EPS of -$3.21, Tourmaline Bio's earnings are expected to decrease next year, from ($3.02) to ($3.56) per share. Upcoming Q2 Earnings DateAug. 14Before Market OpensEstimatedConsensus EPS (May. 2) -$0.91 Actual EPS (May. 2) -$0.89 Beat By $0.02 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)SEC FilingTRML Upcoming EarningsTourmaline Bio's Q2 2025 earnings is scheduled for Thursday, August 14, 2025Powered by Get Tourmaline Bio Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tourmaline Bio and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTRML Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Tourmaline Bio Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.85-$0.85-$0.85Q2 20253-$0.97-$0.90-$0.93Q3 20253-$1.00-$0.74-$0.88Q4 20253-$0.96-$0.80-$0.89 FY 2025 11 -$3.78 -$3.29 -$3.55 Q1 20261-$0.93-$0.93-$0.93Q2 20261-$0.94-$0.94-$0.94Q3 20261-$0.95-$0.95-$0.95Q4 20261-$0.96-$0.96-$0.96 Tourmaline Bio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/14/2025(Estimated)--------5/2/2025Q1 2025-$0.91-$0.89+$0.02-$0.89--3/13/2025Q4 2024-$0.91-$0.86+$0.05-$0.86-$0.04M11/7/2024--$0.84-$0.78+$0.06-$0.78--8/8/2024--$0.72-$0.68+$0.04-$0.68--5/13/2024Q1 2024-$0.68-$0.55+$0.13-$0.55--3/19/2024Q4 2023-$0.75-$0.81 -$0.06-$0.81--11/14/2023Q3 2023-$0.94-$1.64 -$0.70-$1.64--8/14/2023Q2 2023--$2.00--$0.50-- Tourmaline Bio Earnings - Frequently Asked Questions When is Tourmaline Bio's earnings date? Tourmaline Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on TRML's earnings history. Did Tourmaline Bio beat their earnings estimates last quarter? In the previous quarter, Tourmaline Bio (NASDAQ:TRML) reported ($0.89) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.91) by $0.02. Learn more on analysts' earnings estimate vs. TRML's actual earnings. How can I view Tourmaline Bio's earnings report? Tourmaline Bio's earnings report can be found in their filing with the SEC. View SEC filing How much profit does Tourmaline Bio generate each year? Tourmaline Bio (NASDAQ:TRML) has a recorded net income of -$73.21 million. TRML has generated -$3.21 earnings per share over the last four quarters. What is Tourmaline Bio's EPS forecast for next year? Tourmaline Bio's earnings are expected to decrease from ($3.02) per share to ($3.56) per share in the next year. More Earnings Resources from MarketBeat Related Companies ARWR Earnings Results IDYA Earnings Results BHC Earnings Results BLTE Earnings Results IBRX Earnings Results IRON Earnings Results AGIO Earnings Results TWST Earnings Results CGON Earnings Results HRMY Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals?Why SoundHound AI's Earnings Show the Stock Can Move HigherAirbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New Era This page (NASDAQ:TRML) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tourmaline Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access